ArticlePloS one2024

From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework.

Jennifer E Lutomski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.